There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 2 | 36 | 438.75 |
| 1 | 45 | 438.55 |
| 1 | 25 | 438.5 |
| 1 | 14 | 438.4 |
| 1 | 6 | 438.35 |
| Ask | Qty | Orders |
|---|---|---|
| 439 | 5 | 22 |
| 439.05 | 1 | 64 |
| 439.2 | 3 | 35 |
| 439.25 | 1 | 14 |
| 439.3 | 1 | 15 |
Annual Revenue,rose 13.27%, in the last year to ₹656.67 Cr. Its sector's average revenue growth for the last fiscal year was 12.14%.Annual Net Profit,rose 35.84% in the last year to ₹5.37 Cr. Its sector's average net profit growth for the last fiscal year was 1.91%.Quarterly Revenue,rose 25.82% YoY to ₹169.3 Cr. Its sector's average revenue growth YoY for the quarter was 13.38%.Panacea Biotec Limited is one of India’s leading research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets. The company is well acknowledged by the United Nations (UN) Health Agencies in partnering the Global Polio Eradication Initiative (GPEI) with supplies of billions of doses of WHO Pre-qualified Polio vaccines in more than 50 countries worldwide as a sequel to the completion of full range of Oral polio vaccines (tOPV, mOPV1, mOPV3 & bOPV (Type1&Type3).
For Q4 FY26, Panacea Biotec Ltd reported: Revenue (Net Sales): ₹1111.20 Cr - Up 11.89% year-on-year from ₹993.10 Cr in Q3 FY26. Net Income (PAT): ₹-1.80 Cr - Up -97.55% year-on-year from ₹-73.60 Cr in Q3 FY26.
Panacea Biotec Ltd has delivered a return of 19.62% over the last 3 months. The stock was trading at ₹368.85 on 27 Apr 2026 and is currently at ₹432.10 as of 27 Jul 2026, reflecting a Gain of ₹63.25 per share over this period.
Panacea Biotec Ltd has delivered 9.32% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹647.00 on 09 Jun 2026 and a 52-week low of ₹292.40 on 30 Mar 2026. It is currently trading at ₹432.10 as of 27 Jul 2026.
The all-time high (ATH) for Panacea Biotec Ltd was ₹607.75, recorded on 09 Jun 2026. At the current price of ₹432.10, the stock is trading 28.90% below its all-time high. The all-time low recorded was ₹64.65 on 04 Jun 2012.
Panacea Biotec Ltd has delivered a 37.21% absolute return over the past 5 years, equivalent to a CAGR of 6.53% per annum. The stock was priced at ₹314.92 in Jul 2021 and has risen to ₹432.10 as of 27 Jul 2026. An investment of ₹1,00,000 in Panacea Biotec Ltd five years ago would be worth ₹1,37,210.00 today.
No,Panacea Biotec Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹432.10, the trailing dividend yield of Panacea Biotec Ltd stands at N/A%.
The intraday low for Panacea Biotec Ltd on the NSE today was ₹431.05. The stock's 52-week low stands at ₹292.40, recorded on 30 Mar 2026. Today's low is 47.42% above the 52-week low, indicating the stock is trading well above its yearly lows.
As of 27 Jul 2026, the share price of Panacea Biotec Ltd is ₹432.10 on the NSE and ₹433.70 on the BSE. The stock opened at ₹442.60, touched a high of ₹447.25 and a low of ₹431.05 during today's session.
Over the last 6 months, Panacea Biotec Ltd has given a return of 26.87%. The stock was priced at ₹347.75 on 27 Jan 2026 and has Rise to ₹432.10 as of 27 Jul 2026, a change of ₹84.35 per share.
The intraday high for Panacea Biotec Ltd on the NSE today (27 Jul 2026) was ₹447.25. This compares to the 52-week high of ₹647.00 recorded on 09 Jun 2026. Today's high was -30.87% below the 52-week high.
